Neutrophil-mediated lung damage: A new COPD phenotype?

Respiration

Volumn 83, Issue 2, 2012, Pages 103-105

  Sin, Don ^a   Van Eeden, Stephan F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE COURSE; DISEASE SEVERITY; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; NEUTROPHIL; NEUTROPHIL COUNT; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ACETYLCYSTEINE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84856446538     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000334178     Document Type: Review

References (13)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-750.
2. Hogg JC, Chu F, Utokaparch S, et al: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
3. Pride NB, Burrows B: Development of impaired lung function: natural history and risk factors; in Caverly P, Pride NB (eds): Chronic Obstructive Pulmonary Disease. London, Chapman & Hall, 1995, pp 69-91.
4. Stoller JK, Aboussouan LS: Alpha1-antitrypsin deficiency. Lancet 2005;365:2225-2236.
5. Rutgers SR, Postma DS, ten Hacken NH, et al: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12-18.
6. Milara J, Juan G, Peiró T, Serrano A, Cortijo J: Neutrophil activation in severe, earlyonset COPD patients versus healthy nonsmoker subjects in vitro: effects of antioxidant therapy. Respiration 2012;83:147-158.
7. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV: A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010;14:9-59.
8. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB: Analysis of the lung microbiome in the 'healthy' smoker and in COPD. PLoS One 2011;6:e16384.
9. Mistry D, Stockley RA: Gamma-glutamyl transferase: the silent partner? COPD 2010;7:285-290.
10. Tamagawa E, Suda K, Wei Y, Xing L, Mui T, Li Y, van Eeden SF, Man SF, Sin DD: Endotoxininduced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun 2009;15:251-258.
11. Kido T, Tamagawa E, Bai N, Suda K, Yang HH, Li Y, Chiang G, Yatera K, Mukae H, Sin DD, Van Eeden SF: Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol 2011;44:197-204.
12. Terashima T, Klut ME, English D, Hards J, Hogg JC, van Eeden SF: Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am J Respir Cell Mol Biol 1999;20:171-177.
13. Kitagawa Y, Van Eeden SF, Redenbach DM, Daya M, Walker BA, Klut ME, Wiggs BR, Hogg JC: Effect of mechanical deformation on structure and function of polymorphonuclear leukocytes. J Appl Physiol 1997;82:1397-1405.